113 related articles for article (PubMed ID: 22261145)
21. Striatal dopaminergic D2 receptor occupancy and clinical efficacy in psychosis exacerbation: a 123I-IBZM study with ziprasidone and haloperidol.
Corripio I; Catafau AM; Perez V; Puigdemont D; Mena E; Aguilar Y; Carrió I; Alvarez E
Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jan; 29(1):91-6. PubMed ID: 15610950
[TBL] [Abstract][Full Text] [Related]
22. Different striatal dopamine D2 receptor occupancy in alcohol dependent patients with or without physical withdrawal symptoms --a study using IBZM-SPECT.
Ebert D; Klein T; Lohrmann C; van Elst LT; Hesslinger B; Juengling FD
J Neural Transm (Vienna); 2002 Sep; 109(9):1215-9. PubMed ID: 12203049
[TBL] [Abstract][Full Text] [Related]
23. [In vivo characteristics of IBZM in rat brains: an agent for quantitative SPECT imaging of dopamine D2 receptors. Preparation of 125I-IBZM and its biodistribution and kinetic properties].
Matsumura K; Toyama H; Nakashima H; Ichise M; Kurami M; Nakagawa T; Maeda H; Takeuchi A; Koga S
Kaku Igaku; 1994 May; 31(5):513-9. PubMed ID: 8028224
[TBL] [Abstract][Full Text] [Related]
24. [Dopamine (D2) receptor SPECT with 123I-iodobenzamide (IBZM) in diagnosis of Parkinson syndrome].
Reiche W; Grundmann M; Huber G
Radiologe; 1995 Nov; 35(11):838-43. PubMed ID: 8657887
[TBL] [Abstract][Full Text] [Related]
25. Subjective effects of AMPT-induced dopamine depletion in schizophrenia: correlation between dysphoric responses and striatal D(2) binding ratios on SPECT imaging.
Voruganti L; Slomka P; Zabel P; Costa G; So A; Mattar A; Awad AG
Neuropsychopharmacology; 2001 Nov; 25(5):642-50. PubMed ID: 11682247
[TBL] [Abstract][Full Text] [Related]
26. Iodine-123-IBZM dopamine D2 receptor and technetium-99m-HMPAO brain perfusion SPECT in the evaluation of patients with and subjects at risk for Huntington's disease.
Ichise M; Toyama H; Fornazzari L; Ballinger JR; Kirsh JC
J Nucl Med; 1993 Aug; 34(8):1274-81. PubMed ID: 8326384
[TBL] [Abstract][Full Text] [Related]
27. [123I]Iodobenzamide binding to the rat dopamine D2 receptor in competition with haloperidol and endogenous dopamine--an in vivo imaging study with a dedicated small animal SPECT.
Nikolaus S; Larisch R; Wirrwar A; Jamdjeu-Nouné M; Antke C; Beu M; Schramm N; Müller HW
Eur J Nucl Med Mol Imaging; 2005 Nov; 32(11):1305-10. PubMed ID: 16003562
[TBL] [Abstract][Full Text] [Related]
28. Synthesis, in vitro binding profile and biodistribution of a 125I-labeled N-benzyl pyrrolidinyl benzamide derivative: a potential radioligand for mapping dopamine D2 receptors.
Saji H; Tanahashi K; Kinoshita T; Iida Y; Magata Y; Yokoyama A
Nucl Med Biol; 1996 Feb; 23(2):121-7. PubMed ID: 8868283
[TBL] [Abstract][Full Text] [Related]
29. Baseline and amphetamine-stimulated dopamine activity are related in drug-naïve schizophrenic subjects.
Abi-Dargham A; van de Giessen E; Slifstein M; Kegeles LS; Laruelle M
Biol Psychiatry; 2009 Jun; 65(12):1091-3. PubMed ID: 19167701
[TBL] [Abstract][Full Text] [Related]
30. D2-dopamine receptor occupancy measured by IBZM-SPECT in relation to extrapyramidal side effects.
Broich K; Grünwald F; Kasper S; Klemm E; Biersack HJ; Möller HJ
Pharmacopsychiatry; 1998 Sep; 31(5):159-62. PubMed ID: 9832346
[TBL] [Abstract][Full Text] [Related]
31. SPECT tracer [(123)I]IBZM has similar affinity to dopamine D2 and D3 receptors.
Videbaek C; Toska K; Scheideler MA; Paulson OB; Moos Knudsen G
Synapse; 2000 Dec; 38(3):338-42. PubMed ID: 11020237
[TBL] [Abstract][Full Text] [Related]
32. [The determination of cerebral dopamine (D2) receptor density by using 123I-IBZM-SPECT in Parkinson disease patients].
Hierholzer J; Cordes M; Schelosky L; Barzen G; Poewe W; Henkes H; Keske U; Horowski R; Felix R
Rofo; 1992 Oct; 157(4):390-8. PubMed ID: 1391843
[TBL] [Abstract][Full Text] [Related]
33. Binding of [123I]iodobenzamide to the rat D2 receptor after challenge with various doses of methylphenidate: an in vivo imaging study with dedicated small animal SPECT.
Nikolaus S; Antke C; Beu M; Kley K; Wirrwar A; Huston JP; Müller HW
Eur J Nucl Med Mol Imaging; 2011 Apr; 38(4):694-701. PubMed ID: 21110190
[TBL] [Abstract][Full Text] [Related]
34. Kinetic analyses of [123I]IBZM SPECT for quantification of striatal dopamine D2 receptor binding: a critical evaluation of the single-scan approach.
Meyer PT; Sattler B; Winz OH; Fundke R; Oehlwein C; Kendziorra K; Hesse S; Schaefer WM; Sabri O
Neuroimage; 2008 Aug; 42(2):548-58. PubMed ID: 18595739
[TBL] [Abstract][Full Text] [Related]
35. Imaging D2-receptors in quinolinic acid lesioned rat striatum with high resolution pinhole SPECT.
Sohlberg A; Jolkkonen J; Ruotsalainen U; Kuikka JT
Nuklearmedizin; 2005; 44(5):N43-5. PubMed ID: 16429586
[No Abstract] [Full Text] [Related]
36. The correlation between striatal dopamine D2/D3 receptor availability and verbal intelligence quotient in healthy volunteers.
Guo JF; Kuang Yang Y; Tsing Chiu N; Lieh Yeh T; See Chen P; Lee IH; Lin Chu C
Psychol Med; 2006 Apr; 36(4):547-54. PubMed ID: 16359604
[TBL] [Abstract][Full Text] [Related]
37. Striatal dopamine D2 receptor binding and dopamine release during cue-elicited craving in recently abstinent opiate-dependent males.
Zijlstra F; Booij J; van den Brink W; Franken IH
Eur Neuropsychopharmacol; 2008 Apr; 18(4):262-70. PubMed ID: 18077142
[TBL] [Abstract][Full Text] [Related]
38. In vivo (123)I IBZM SPECT imaging of striatal dopamine 2 receptor occupancy in schizophrenic patients.
Barnas C; Quiner S; Tauscher J; Hilger E; Willeit M; Küfferle B; Asenbaum S; Brücke T; Rao ML; Kasper S
Psychopharmacology (Berl); 2001 Sep; 157(3):236-42. PubMed ID: 11605078
[TBL] [Abstract][Full Text] [Related]
39. Striatal amphetamine-induced dopamine release in patients with schizotypal personality disorder studied with single photon emission computed tomography and [123I]iodobenzamide.
Abi-Dargham A; Kegeles LS; Zea-Ponce Y; Mawlawi O; Martinez D; Mitropoulou V; O'Flynn K; Koenigsberg HW; Van Heertum R; Cooper T; Laruelle M; Siever LJ
Biol Psychiatry; 2004 May; 55(10):1001-6. PubMed ID: 15121484
[TBL] [Abstract][Full Text] [Related]
40. Test-retest variability and reliability of 123I-IBZM SPECT measurement of striatal dopamine D2 receptor availability in healthy volunteers and influence of iterative reconstruction algorithms.
Catafau AM; Bullich S; Danús M; Penengo MM; Cot A; Abanades S; Farré M; Pavía J; Ros D
Synapse; 2008 Jan; 62(1):62-9. PubMed ID: 17960766
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
